Assessing frailty to predict outcomes in older gynecologic cancer patients
Official title: Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients Undergoing Surgery and Chemotherapy
Run by Population Health Research Institute · NCT05738252 · Data updated 2026-11-12
This study is testing if checking for frailty before surgery can better predict recovery and complications for older women with gynecologic cancer compared to standard heart health checks.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 55 Years to 110 Years |
| Sex | Women only |
| Enrollment | 280 (estimated) |
| Sponsor | Population Health Research Institute Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 4 sites (Hamilton, Ontario and 3 other locations) |
| Status | Recruiting |
| Started | June 15, 2023 |
| Main results expected | May 2025 |
| Study ends | October 2025 |
| Registry record updated | April 16, 2025 |
| Trial ID | NCT05738252 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 55 or older with confirmed or suspected gynecologic cancer who are scheduled for cytoreductive surgery.
✕Probably not a fit
Patients requiring urgent surgery, those with cognitive impairments, or those undergoing neoadjuvant radiation therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of preoperative frailty assessments using the Frailty Phenotype compared to traditional cardiovascular risk assessments in predicting postoperative outcomes for patients aged 55 and older with gynecologic cancer. By focusing on patients undergoing high-risk surgeries, the study seeks to fill knowledge gaps regarding postoperative recovery and complications. The findings could lead to improved clinical practices and inform future decision-making strategies in gynecologic oncology care.
Why it matters
Potential benefit: If successful, this study could enhance the prediction of postoperative outcomes, leading to better tailored care for older gynecologic cancer patients.
How similar studies have gone: While there is growing literature on frailty assessments in noncardiac surgery, studies specifically involving gynecologic oncology patients are limited and of low quality, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age must be 55 years or older at registration 2. Must meet any one of the following criteria: 1. Have stage II-IV ovarian or endometrial cancer, undergoing cytoreductive surgery via laparotomy, with or without neoadjuvant chemotherapy (NACT) 2. Have any stage endometrial, uterine or cervical cancer planned for laparotomy where laparoscopy is deemed unfeasible/high-risk due to comorbidities 3. Are undergoing laparotomy for pelvic mass, highly suspicious for malignancy; or 4. Are undergoing laparotomy for gynecologic malignancy recurrence. Exclusion Criteria: 1. Unable to provide informed consent 2. Require urgent surgery within 24 hours of first consultation to the Gynecological Oncology team 3. Are undergoing neoadjuvant radiation therapy 4. Have a previously documented history of dementia 5. Have cognitive, language, vision, or hearing impairment that impacts ability to understand the directions for the completion of the study instruments 6. Are participating in a clinical trial investigating a new systemic therapy
Where it's running
-
Juravinksi Hospital
Hamilton, Ontario, Canada Recruiting -
Credit Valley Hospital
Mississauga, Ontario, Canada Recruiting -
Sunnybrook
Toronto, Ontario, Canada Recruiting -
University Health Network
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Maura Marcucci, MD — Population Health Research Institute
- Study coordinator: Julie My Van Nguyen, MD
- Email: nguyenjmv@HHSC.CA
- Phone: 905-521-2100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using ultrasound to measure muscle mass in older women with gynecologic cancer to predict hospital stay length
This study is testing if using ultrasound to measure muscle mass in older women with gynecologic cancer can help predict how long they will stay in the hospital after surgery.
-
NMTCuff vs standard TOF monitoring during gynecologic oncology surgery
This study tests whether NMTCuff monitoring can better detect neuromuscular recovery than standard TOF monitoring in women undergoing laparoscopic gynecologic cancer surgery.
-
Postprandial drop and frailty in older adults having planned noncardiac surgery
This study tests whether a drop in blood pressure after meals and frailty predict low blood pressure after anesthesia starts in adults 65 and older undergoing planned noncardiac surgery.
-
Frailty Training for Emergency Nurses in Morocco
This trial tests whether a four-module training program helps Moroccan emergency nurses recognize and care for frail older adults in the ER.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Physical Function and Fall Risk in Older Adults in Lalín's Frailty Prevention Program
This study will look at how physical function and fall risk change in people 70 and older who participate in a routine frailty and falls prevention program, by comparing assessments before and after the 8–12 week program.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.